Cigna Group (CI) remains on track with its "stop-loss recovery" and its business continues to avoid several broader managed care pressures, with minimal government exposure, Oppenheimer said in a note Thursday.
The company aims to recover 100 basis points of margin between 2026 and 2027 through its stop-loss recovery strategy, the investment firm said.
Cigna's Q2 results met expectations, with balanced growth across its business segments and the company highlighting the performance of its Evernorth health services business, particularly its strong retention rates, according to Oppenheimer.
"Overall, Cigna remains well-positioned, with a balanced/stable portfolio, exposure to high-growth markets, and an attractive valuation," analysts said, adding that recent managed care weakness presents a long-term buying opportunity.
Oppenheimer reiterated its outperform rating on Cigna Group, while lowering its price target to $365 from $375.
Shares of Cigna were down about 1.9% in recent trading Friday.
Price: 262.40, Change: -4.98, Percent Change: -1.86
Comments